[ALNY] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
19-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -218.88%
YoY- -334.79%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 7,551 24,019 10,847 8,495 20,455 21,192 26,626 -18.93%
PBT -90,721 -43,480 -29,336 -72,760 -14,303 -6,503 -8,230 49.15%
Tax -6,685 -22,091 3,021 -10,572 -237 427 -439 57.40%
NP -90,721 -21,389 -32,357 -62,188 -14,303 -6,930 -7,791 50.52%
Tax Rate - - - - - - - -
Total Cost 98,272 45,408 43,204 70,683 34,758 28,122 34,417 19.09%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -1,201.44 -89.05 -298.30 -732.05 -69.92 -32.70 -29.26 85.68%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -1.07 -0.28 -0.51 -1.20 -0.31 -0.16 -0.19 33.36%
EPS Diluted -1.07 -0.28 -0.51 -1.20 -0.31 -0.16 -0.19 33.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.